Clinical Trial Update: Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Veramyst for reducing nasal and ocular symptoms after early allergen exposure in allergic rhinitis. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Veramyst (fluticasone furoate)

Snippet

Sponsor: University of Chicago | Conditions: Allergic Rhinitis | Phase 4 | Status: COMPLETED | Results posted: 2014-07-08